HNSCC tumors are characteristically very heterogenous, whether by location, etiology (HPV-related versus smoking-related), or biomarkers (PD-L1 expressing versus not) and we have learned that these patient and tumor traits can predict the varied biological responses to therapies. Here, CD274 is linked to head and neck squamous cell carcinoma.